hearing

FDA pushes off stem cell hearing

The Food and Drug Administration has indefinitely postponed a public hearing on stem cell regulation due to what it called “considerable interest.” “Due to this interest, and to give stakeholders additional time to provide comments to the agency, FDA intends to extend the comment period for the draft guidance documents,” the administration said on its website. The April 13 hearing was shaping up as a public showdown between opponents and supporters of stem cell-based research…